New colorimetric cytotoxicity assay for anticancer-drug screening | Journal of the National Cancer Institute | 1990 | 7.4K |
Response criteria for phase II studies of supratentorial malignant glioma | Journal of Clinical Oncology | 1990 | 2.1K |
Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10 | Cancer Research | 1990 | 1K |
Hypersensitivity reactions from taxol | Journal of Clinical Oncology | 1990 | 989 |
Taxol: a novel investigational antimicrotubule agent | Journal of the National Cancer Institute | 1990 | 871 |
Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture | Cancer Research | 1990 | 801 |
Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines | Journal of the National Cancer Institute | 1990 | 799 |
p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis | Cancer Research | 1990 | 731 |
Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study | Gynecologic Oncology | 1990 | 730 |
The role of 8-hydroxyguanine in carcinogenesis | Carcinogenesis | 1990 | 684 |
Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist | British Journal of Cancer | 1990 | 683 |
Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia | Journal of Clinical Oncology | 1990 | 638 |
Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family | Oncogene | 1990 | 634 |
Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies | Journal of the National Cancer Institute | 1990 | 614 |
Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression | Cancer Research | 1990 | 580 |
Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer | Cancer Research | 1990 | 541 |
Increased cell division as a cause of human cancer | Cancer Research | 1990 | 539 |
A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors | Journal of Clinical Oncology | 1990 | 529 |
Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents | Cancer Research | 1990 | 519 |
Family history and the risk of prostate cancer | Prostate | 1990 | 518 |
Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15 | Journal of Clinical Oncology | 1990 | 514 |
Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more | Journal of the National Cancer Institute | 1990 | 510 |
Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer | Journal of Clinical Oncology | 1990 | 509 |
Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy | Cancer Research | 1990 | 507 |
Inhibition of protein phosphatases by microcystins and nodularin associated with hepatotoxicity | Journal of Cancer Research and Clinical Oncology | 1990 | 495 |